Zeta Global shares dropped 5.1% in pre-market trading after the company published its Q2 2026 results following the prior session's close. The the headline that weighed heaviest on the stock was a GAAP earnings-per-share figure of $0.03 versus an analyst consensus near $0.20, representing an approximately 85% shortfall from expectations.
On the revenue side, the report painted a stronger picture. Zeta posted quarterly revenue of $443 million, topping Wall Street's estimate of about $421 million by more than 5% and marking 44% year-over-year growth. The company also raised full-year 2026 revenue guidance to roughly $1.818 billion at the midpoint, up from prior guidance of about $1.785 billion, and set Q3 2026 revenue guidance in a range of $469 million to $472 million - above a then-prevailing analyst consensus of $461 million.
Profitability metrics included adjusted EBITDA of $92 million for the quarter, representing a 20.7% margin and beating estimates by more than 6%. Management also reported the company's first positive GAAP net income, a milestone it had been targeting. Despite those operational positives, the market's focus landed on the large GAAP EPS shortfall.
Company commentary and filings indicate the EPS miss was driven in part by costs related to the Marigold acquisition. Those acquisition-related costs were large enough to overshadow otherwise solid revenue execution, raised guidance and an improving adjusted-EBITDA profile.
Several contextual factors compounded the market's reaction. The stock had rallied notably in the session before the report, which lifted expectations going into the print. Additionally, net insider selling ahead of the release was flagged as a factor that likely amplified investor concern. Taken together, an elevated consensus, a headline EPS miss, and insider selling appear to have created the conditions for the pre-market decline.
Market-wide performance offered little explanation for the move. The S&P 500 was up about 0.3%, the Dow Jones also added about 0.3%, and the Nasdaq was essentially flat at roughly -0.04% at the time of the drop in Zeta shares, indicating the weakness was company-specific rather than the result of broader equity-market pressure.
In short, the quarter presented a mixed picture: accelerating top-line growth, raised guidance and stronger adjusted EBITDA countered by a materially lower-than-expected GAAP EPS driven by acquisition-related costs and amplified by pre-report positioning in the stock. Investors assessing Zeta's shares must weigh the improving operating metrics against near-term GAAP earnings volatility tied to integration and transaction expenses.
Key points
- Zeta reported GAAP EPS of $0.03 versus about $0.20 consensus, an approximate 85% miss.
- Revenue was $443 million, surpassing estimates of roughly $421 million and rising 44% year-over-year; full-year revenue guidance was raised to a midpoint near $1.818 billion.
- Adjusted EBITDA was $92 million at a 20.7% margin, and the company recorded its first positive GAAP net income. The stock's pre-market decline appears company-specific, with major U.S. indexes showing minimal movement.
Risks and uncertainties
- Acquisition-related costs - Expenses tied to the Marigold acquisition materially reduced GAAP EPS, introducing near-term earnings volatility that could influence investor sentiment toward the company's shares. This risk primarily affects equity holders.
- Elevated expectations - The stock had rallied before the earnings release, suggesting that prior gains may have priced in a strong result; heightened expectations can magnify downside moves when results miss headlines.
- Insider activity - Net insider selling ahead of the report was noted as a possible contributor to the pre-market pullback, creating uncertainty about insider sentiment and timing for the equity.